← Back to Search

Smoke-Free Homes Intervention for Smoking Cessation (SFH 5A RCT Trial)

N/A
Waitlist Available
Led By Michelle Kegler, MD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
adults unable to consent
18 years of age and older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months,12 months
Awards & highlights

SFH 5A RCT Trial Summary

This trial will test whether adding an intervention to create smoking bans in homes and vehicles to existing clinical guidelines for quitting smoking will help low-income patients sustain quitting smoking.

Who is the study for?
This trial is for adult smokers referred by a primary care physician from a participating health center in South Georgia, who have smoked recently but aren't in another cessation program. Participants must speak and understand English, be the only person from their household to join, and not be pregnant or unable to consent.Check my eligibility
What is being tested?
The study tests if adding a smoke-free homes intervention into tobacco quitting guidelines helps people stop smoking. It includes three mailings and two coaching calls aimed at creating no-smoking rules at home and in cars.See study design
What are the potential side effects?
Since this trial involves behavioral interventions like coaching calls and educational materials rather than medications, it does not have typical medical side effects. However, participants may experience stress or frustration while trying to quit smoking.

SFH 5A RCT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am unable to give consent for medical procedures.
Select...
I am 18 years old or older.
Select...
I cannot clearly understand English.
Select...
I have difficulty making decisions due to cognitive impairment.

SFH 5A RCT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months,12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months,12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants who achieved smoking cessation/abstinence
Secondary outcome measures
Change in number of cigarettes smoked in the home
Change in number of cigarettes smoked per day on smoking days
Duration of abstinence (i.e. days since last use) at 12-month follow up
+6 more

Side effects data

From 2012 Phase 4 trial • 200 Patients • NCT01342510
30%
Pain with injection of propofol
100%
80%
60%
40%
20%
0%
Study treatment Arm
Lidocaine/Magnesium
Control
Lidocaine
Magnesium

SFH 5A RCT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Smoke-Free Homes InterventionExperimental Treatment2 Interventions
Participants in the intervention condition will receive the expanded Smoke-Free Homes intervention coupled with a connection to the quitline. Follow-up will be at six and twelve months, including saliva cotinine validation for reported 7-day cessation.
Group II: ControlActive Control1 Intervention
The usual care/control arm will receive mailed information on the quitline and a connection to the quitline at their request. Follow-up will be at six and twelve months, including saliva cotinine validation for reported 7-day cessation.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Control
2011
Completed Phase 4
~15780

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,627 Previous Clinical Trials
2,559,421 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,679 Previous Clinical Trials
6,909,338 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,609 Previous Clinical Trials
40,914,302 Total Patients Enrolled

Media Library

Smoke-Free Homes intervention Clinical Trial Eligibility Overview. Trial Name: NCT04547686 — N/A
Smoking Cessation Research Study Groups: Smoke-Free Homes Intervention, Control
Smoking Cessation Clinical Trial 2023: Smoke-Free Homes intervention Highlights & Side Effects. Trial Name: NCT04547686 — N/A
Smoke-Free Homes intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04547686 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research initiative currently available to participants?

"Clinicaltrials.gov provides evidence that this medical study, initially published on November 11th 2020 and last amended on July 26th 2022, is no longer searching for participants. Luckily though, 142 other clinical trials are currently recruiting patients at the moment."

Answered by AI
~401 spots leftby Sep 2025